Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Press Release

Tauopathies market entry requires shrewd strategies from pharma companies

Pharmaceutical companies hoping to effectively compete in the tauopathies space, which is yet to see its first drug hit the market, are adopting a broad range of strategies including entering into licensing agreements and partnerships for the co-development of products, and pursuing multiple indications and drug candidates, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Rheumatoid arthritis market will hit $28.5 billion by 2025

The rheumatoid arthritis space across the eight major markets (8MM) of the US, France, Germany, Italy, Spain, the UK, Japan, and Australia, is set to grow from $19.5 billion in 2015 to around $28.5 billion by 2025, representing a compound annual growth rate of 3.9%, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Tauopathy drugs for neurodegenerative diseases could take off after first-to-market drug is launched

The tauopathies market, which covers more than 20 neurodegenerative diseases such as progressive supranuclear palsy and corticobasal degeneration characterized by tau protein aggregation in the brain, will be driven primarily by the development of novel therapeutics with a first-to-market drug boosting sales and encouraging pharma companies to focus R&D efforts on this market, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Spirit drinkers keen to experiment with novel flavors but crave authenticity

As global spirit drinkers become more experimental, with at least 39% of them actively trying new varieties within each category, craft distillers are presented with an opportunity to diversify their product portfolio. This can be done by adding unique ingredients, trying unusual ingredient combinations, and using innovative processes, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

37% of financial advisors in the UK are using discretionary fund managers for their clients’ investments

The UK financial advice landscape is facing increased compliance pressure from regulators as well as cost concerns from clients due to greater competition in the market. As such, independent financial advisors (IFAs) are increasingly looking to move away from traditional fund selection strategies towards outsourcing aspects of investment management, according to GlobalData, a recognized leader in providing business information and analytics.
Read more
1 … 58 59 60 61